Vitamin C sensitizes triple negative breast cancer to PI3K inhibition therapy

Conclusion: Vitamin C can be used to reduce the dosage of buparlisib needed to produce a therapeutic effect, which could potentially ease the dose-dependent side effects in patients.

Source: Theranostics - April 19, 2021 Category: Molecular Biology Authors: Sushmita Mustafi, Vladimir Camarena, Rehana Qureshi, David W. Sant, Zachary Wilkes, Daniel Bilbao, Joyce Slingerland, Susan B. Kesmodel, Gaofeng Wang Tags: Research Paper Source Type: research